Oil prices rise on prospects for U.S.-China trade deal
Oil prices rose on Tuesday buoyed by prospects of a trade deal, but concerns about demand limited the gains....
Trump calls impeachment inquiry a ‘lynching’
U.S. President Donald Trump likened the impeachment investigation into his dealings with Ukraine to a “lynching” on Tuesday in a tweet that drew condemnation for...
Fiat Chrysler to build new battery hub in Turin
Fiat Chrysler will build a new battery assembly complex in its Mirafiori plant in Turin, with an initial investment of 50 million euros ($56 million),...
UPS COO’s retirement eclipses e-commerce gains
United Parcel Service Inc’s e-commerce fueled quarterly profit beat on Tuesday was overshadowed by news that Jim Barber, widely viewed as the world’s biggest parcel...
UTC says Boeing 737 MAX production could remain at current levels
United Technologies believes Boeing will still make 737 MAX planes at its current rate for the rest of 2019, Chief Financial Officer Akhil Johri said...
Five U.S. officials including Kushner, Mnuchin to attend Saudi financial conference: sources
U.S. Treasury Secretary Steven Mnuchin and presidential adviser Jared Kushner will lead Washington’s delegation to an annual financial conference in Saudi Arabia, government sources said...
Zuckerberg to tell Congress Facebook is ‘not the ideal messenger’ for Libra currency
Facebook Chief Executive Mark Zuckerberg plans to acknowledge before Congress that Facebook is not the “ideal messenger” for its Libra cryptocurrency project, given ongoing criticism...
McDonald’s misses profit target as competition delivers breakfast, plant burgers
McDonald’s Corp missed Wall Street estimates for profit for the first time in two years on Tuesday as more investment to spruce up U.S. restaurants...
Trump adviser Stone loses bid to lift court-imposed gag order as trial looms
U.S. President Donald Trump’s former adviser Roger Stone lost a last-ditch effort on Tuesday to lift a court-imposed gag order barring him from posting on...
Biogen resurrects Alzheimer’s drug, stock soars
Shares of Biogen skyrocketed roughly 40 percent Tuesday after the biotech company said it will seek approval for an Alzheimer’s treatment after abandoning the drug...
